A Study of BMS-986171 in Healthy People to Assess Safety, to Measure Blood Levels of Drug, and to Find Out What the Drug Does to the Body

• Status: Completed
• Trial end date: 2016-11-05
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to assess safety, to measure blood levels of drug, and to find out what the drug does to the body.

• Phase: Phase 1
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Bristol-Myers Squibb

Criteria

For more information regarding BMS clinical trial participation, please visit www.BMSStudyConnect.com

Inclusion Criteria:

• Age 21 to 55 years (Part A,B, and C)

• BMI 30-40 (Part A or Part B); BMI 20-35 (Part C). BMI = weight (kg)/ [height (m)]

Exclusion Criteria:

• Any significant medical illness

• Cannot tolerate subcutaneous injections, or having blood samples taken

• Smoking more than 10 cigarettes/day

• History of allergy to pegylated compounds or of hypersensitivity to protein based therapeutics.

• HIV, Hepatitis B virus (HBV) or Hepatitis C virus (HCV) infection.

• Pregnancy